James F. Oliviero III, the CEO, President, and Director of Checkpoint Therapeutics , Inc. (NASDAQ:CKPT), recently sold shares ...
William Garrett Gray, the Chief Financial Officer of Checkpoint Therapeutics , Inc. (NASDAQ:CKPT), recently sold 74,110 shares of the company’s common stock. The shares were sold at a weighted average ...
A look at the shareholders of Checkpoint Therapeutics, Inc. ( NASDAQ:CKPT) can tell us which group is most powerful. With 56% stake, individual investors possess the maximum shares in the company. In ...
There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on QuidelOrtho (QDEL – Research Report) and Palatin ...
Enhance your stock picks with dividend metrics like per-share dividends, yield, frequency, payout ratios, and more.
Elevate your confidence by analyzing investor sentiment and stock portfolio shifts, then make your own decisions.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results